Today

Agents

Chat

Arena

Discover

More

App

AbbVie <ABBV.N>: BMO Raises Target Price to $300 From $258

ABBV•2026-07-13

Related News

Q32 Bio soars as hair-loss drug shows scalp hair regrowth in mid-stage study

QTTB•2026-07-13

EyePoint names Tarek Hassan chief strategic science officer

EYPT•2026-07-13

Valero Energy Corp <VLO.N>: Raymond James raises target price to $340 from $300

VLO•2026-07-13

Vertex Pharmaceuticals Inc <VRTX.O>: Truist Securities Raises Target Price to $560 From $542

VRTX•2026-07-13

DTE Energy Co <DTE.N>: BMO cuts target price to $152 from $154

DTE•2026-07-13

AbbVie <ABBV.N>: BMO Raises Target Price to $300 From $258 - ABBV News | Rallies